Heparin-induced thrombocytopenia history and symptoms: Difference between revisions
Jump to navigation
Jump to search
Line 10: | Line 10: | ||
** High titer platelet-activating antibodies that have both increased heparin-dependent and heparin independent platelet activation | ** High titer platelet-activating antibodies that have both increased heparin-dependent and heparin independent platelet activation | ||
** The phenomena is sometimes explained by the fact that unusually high antibody levels react with platelet-associated Platelet Factor 4 (PF4) bound to non-heparin [[glycosaminoglycans]] like [[chondroitin sulfate]] and not to heparin. | ** The phenomena is sometimes explained by the fact that unusually high antibody levels react with platelet-associated Platelet Factor 4 (PF4) bound to non-heparin [[glycosaminoglycans]] like [[chondroitin sulfate]] and not to heparin. | ||
* The incidence of delayed onset [[HIT]] are less compared to other forms of HIT. | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 15:52, 4 December 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Heparin-induced thrombocytopenia is diagnosed when the platelet count falls by > 50% typically after 5-10 days of heparin therapy. Unlike other immune mediated thrombocytopenia (idiopathic thrombocytopenic purpura), the levels of platelet stays > 20,000 microl, thus frank clinical bleeding is less common in HIT when compared to other conditions, where the platelet may fall below 10,000/ microl.
History
- Occurs commonly after 5-10 days of initiation of heparin therapy. Onset of HIT after 2 weeks of heparin therapy is uncommon. Earlier onset of HIT is usually seen in patients who have been previously treated with heparin (1-3 months back) and have circulating HIT antibodies in them. In these patients the median time of platelet fall is less than 12 hours after the start of heparin administration
- Delayed onset HIT:
- Occurs after heparin has been withdrawn (median time of 14 days after heparin withdrawl)
- High titer platelet-activating antibodies that have both increased heparin-dependent and heparin independent platelet activation
- The phenomena is sometimes explained by the fact that unusually high antibody levels react with platelet-associated Platelet Factor 4 (PF4) bound to non-heparin glycosaminoglycans like chondroitin sulfate and not to heparin.
- The incidence of delayed onset HIT are less compared to other forms of HIT.